Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies.
Pharma’s dealmaking tear; Blackstone raises record fund; Xolair energizes allergy research; and more
Welcome back to Endpoints Weekly! They say March comes in like a lion and out like a lamb, but two pharma giants made a roar


